1.
Secukinumab’s Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment. J of Skin [Internet]. 2018 Feb. 23 [cited 2026 Apr. 18];2(S1):S18. Available from: https://skin.dermsquared.com/skin/article/view/297